BNP Paribas Financial Markets’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $91.1K | Sell |
|
|||||
|
2022
Q1 | $524K | Sell |
|
|||||
|
2021
Q4 | $1.21M | Buy |
|
|||||
|
2021
Q3 | $83.9K | Buy |
|
|||||
|
2021
Q2 | $28.5K | Sell |
|
|||||
|
2021
Q1 | $224K | Buy |
|
|||||
|
2020
Q4 | $119K | Sell |
|
|||||
|
2020
Q3 | $249K | Buy |
|
|||||
|
2020
Q2 | $164K | Sell |
|
|||||
|
2020
Q1 | $532K | Buy |
|
|||||
|
2019
Q4 | $270K | Sell |
|
|||||
|
2019
Q3 | $142K | Buy |
|
|||||
|
2019
Q2 | $106K | Sell |
|
|||||
|
2019
Q1 | $169K | Buy |
|
|||||
|
2018
Q4 | $7.68K | Sell |
|
|||||
|
2018
Q3 | $32.1K | Buy |
|
|||||
|
2018
Q2 | $37.9K | Sell |
|
|||||
|
2018
Q1 | $179K | Buy |
|
|||||
|
2017
Q4 | $126K | Buy |
|
|||||
|
2017
Q3 | $96.7K | Sell |
|
|||||
|
2017
Q2 | $78.5K | Buy |
|
|||||
|
2017
Q1 | $15.4K | Sell |
|
|||||
|
2016
Q4 | $35K | Sell |
|
|||||
|
2016
Q3 | $32.7K | Buy |
|
|||||
|
2016
Q2 | $16.7K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $97.2K | Sell |
|
|||||
|
2015
Q3 | $79.9K | Buy |
|
|||||
|
2015
Q2 | $58K | Buy |
|
|||||
|
2015
Q1 | $5.62K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $18.2K | Buy |
|
|||||
|
2014
Q2 | $4.76K | Buy |
|
|||||
|
2014
Q1 | $1.29K | Buy |
|
|||||
|
2013
Q4 | $666 | Buy |
|